sharanyaglobal.com - /upload/pdf/


[To Parent Directory]

7/8/2025 12:41 PM 237 .htaccess
7/8/2025 12:41 PM 53722 0dFBU_7.png
7/8/2025 12:41 PM 3785167 0dqrq_1. Therapeutic efficacy of 225Ac‑PSMA‑617 Targeted Alpha Therapy in patients of Metastatic Castrate Resistant Prostate Cancer after Taxane‑Based Chemotherapy.pdf
7/8/2025 12:41 PM 2023451 39Jyb_2. Clinical Connect - Oncology - New Challenges, New Strategies.pdf
7/8/2025 12:41 PM 69850 5oon4_nmt_pdf_3.jpg
7/8/2025 12:41 PM 145663 9ikf5_5.png
7/8/2025 12:41 PM 119589 Case-Study-Lutetium-177-PSMA.png
7/8/2025 12:41 PM 3297117 Case-Study-Lutetium-Therapy-Pluvicto.pdf
7/8/2025 12:41 PM 118159 Case-Study-Lutetium-Therapy-Pluvicto.png
7/8/2025 12:41 PM 118078 Case-Study-Lutetium-Therapy.png
7/8/2025 12:41 PM 2023451 Clinical Connect - Oncology - New Challenges, New Strategies.pdf
7/8/2025 12:41 PM 115040 DB8dB_5.png
7/8/2025 12:41 PM 2023451 DB8dB_Clinical-Connect-Oncology.pdf
7/8/2025 12:41 PM 154293 EdbgN_nmt_pdf_5.png
7/8/2025 12:41 PM 828662 eQsfj_4. Exceptional Response to 177Lutetium Prostate-Specific Membrane Antigen in Prostate Cancer Harboring DNA Repair Defects (1).pdf
7/8/2025 12:41 PM 828662 Exceptional Response to 177Lutetium Prostate-Specific Membrane Antigen in Prostate Cancer Harboring DNA Repair Defects (1).pdf
7/8/2025 12:41 PM 828662 Exceptional Response to 177Lutetium Prostate-Specific Membrane Antigen in Prostate Cancer Harboring DNA Repair Defects.pdf
7/8/2025 12:41 PM 828662 Exceptional Response.pdf
7/8/2025 12:41 PM 6866530 In-House.pdf
7/8/2025 12:41 PM 6866530 In‑House Preparation and Quality Control.pdf
7/8/2025 12:41 PM 6866530 In‑House.pdf
7/8/2025 12:41 PM 120342 iwf9Z_7.png
7/8/2025 12:41 PM 828662 iwf9Z_Exceptional-Response.pdf
7/8/2025 12:41 PM 125831 j1cTP_2.png
7/8/2025 12:41 PM 3785167 j1cTP_Therapeutic-efficacy.pdf
7/8/2025 12:41 PM 125831 jq2uu_2.png
7/8/2025 12:41 PM 3785167 jq2uu_Therapeutic-efficacy.pdf
7/8/2025 12:41 PM 2023451 Ld3Uz_2. Clinical Connect - Oncology - New Challenges, New Strategies.pdf
7/8/2025 12:41 PM 330505 Lutetium-PRRT-for-Metastatic-well-differentiated-Neuroendocrine-Tumor.pdf
7/8/2025 12:41 PM 34942 lutetium-prrt-for-metastatic-well.jpg
7/8/2025 12:41 PM 61506 LYQmU_nmt_pdf_2.jpg
7/8/2025 12:41 PM 126159 M3D7s_6.png
7/8/2025 12:41 PM 120295 mTA5H_3.png
7/8/2025 12:41 PM 5782053 PSMA-case-study-2.pdf
7/8/2025 12:41 PM 39099 QPJ5U_6.png
7/8/2025 12:41 PM 61372 rAOMI_nmt_pdf_1.jpg
7/8/2025 12:41 PM 133491 rb4Pj_2.png
7/8/2025 12:41 PM 121380 sXp4q_4.png
7/8/2025 12:41 PM 3785167 Therapeutic efficacy.pdf
7/8/2025 12:41 PM 118370 U5KNT_8.png
7/8/2025 12:41 PM 596808 U5KNT_Vision-Trial-Lutetium.pdf
7/8/2025 12:41 PM 596808 Vision Trial-Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.pdf
7/8/2025 12:41 PM 43465 wmxps_8.png
7/8/2025 12:41 PM 46952 X8LPq_nmt_pdf_1.jpg
7/8/2025 12:41 PM 102613 xBdan_nmt_pdf_4.jpg
7/8/2025 12:41 PM 123340 xpFc0_tst.png
7/8/2025 12:41 PM 175497 yl9UL_4 (1).png